Lamotrigine Extended Release Tablet
Product Images NDC 49884-561

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine Extended Release (NDC 49884-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine Er Tabs 1)

Chemical Structure (Lamotrigine Er Tabs 1)
Chemical structure of lamotrigine, showing its molecular framework including chlorine atoms and amino groups as part of the compound.*
FDA Label Image

Lamotrigine Er Tablets 300 mg Label (Lamotrigine Er Tabs 10)

Lamotrigine Er Tablets 300 mg Label (Lamotrigine Er Tabs 10)
Label for Lamotrigine Extended-Release Tablets 300 mg by Par Pharmaceutical. The label states once-a-day dosing with 30 tablets per container. It includes warnings to dispense medication guides and verify product dispensed, plus storage instructions and manufacturer information.*
FDA Label Image

This Is Figure 1 (Lamotrigine Er Tabs 2)

This Is Figure 1 (Lamotrigine Er Tabs 2)
A cumulative responder rate graph comparing Lamotrigine Extended Release and placebo treatments. The x-axis shows percent of patients from 100 to 0, and the y-axis shows responder rate ranging from worsening (-100%) to improvement (100%). Two lines represent treatment groups: a solid line for Lamotrigine ER (N=70) and a dashed line for placebo (N=73), illustrating the difference in responder rates between the groups.*
FDA Label Image

Fig1 (Lamotrigine Er Tabs 3)

Fig1 (Lamotrigine Er Tabs 3)
A line graph depicting responder rates for Lamotrigine Extended Release (Lamotrigine ER) and placebo groups across percent of patients. The x-axis represents percent of patients from 100 to 0, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). Two lines illustrate response trends: a solid line for Lamotrigine ER (N=116) and a dotted line for placebo (N=120).*
FDA Label Image

Tablet Images (Lamotrigine Er Tabs 4)

Tablet Images (Lamotrigine Er Tabs 4)
Lamotrigine Extended Release Tablets by Par Health USA, LLC shown in various dosages and corresponding tablet colors: 25 mg (beige), 50 mg (light orange), 100 mg (light brown), 200 mg (yellow), 250 mg (light gray), and 300 mg (dark gray). Each tablet is round and imprinted with the respective dosage and the labeler name 'Par.'*
FDA Label Image

Lamotrigine Er Tablets 25 mg Label (Lamotrigine Er Tabs 5)

Lamotrigine Er Tablets 25 mg Label (Lamotrigine Er Tabs 5)
Label for Lamotrigine Extended-Release Tablets 25 mg, showing the product name, strength, and dosage form as extended-release tablets. The label includes the NDC 49884-561-11 and indicates a package of 30 tablets. It displays the Par Health USA, LLC logo and name as the labeler. Additional labeling details include storage instructions, dosage note to see package insert, cautions about medication guides, and that the tablets are round and scored with imprint 'Par' and '561.' Barcodes and manufacturing information are also visible.*
FDA Label Image

Lamotrigine Er Tablets 50 mg Label (Lamotrigine Er Tabs 6)

Lamotrigine Er Tablets 50 mg Label (Lamotrigine Er Tabs 6)
Lamotrigine Extended Release Tablets 50 mg, presented in a package of 30 tablets by Par Health USA, LLC. The label indicates the product is once-a-day, extended-release film-coated tablets. It includes usage instructions to dispense the accompanying medication guide and cautions to verify the product dispensed. Manufacturer details and storage instructions are also visible, along with a barcode and images of two white round tablets marked 'Par' and '562'.*
FDA Label Image

Lamotrigine Er Tablets 100 mg Label (Lamotrigine Er Tabs 7)

Lamotrigine Er Tablets 100 mg Label (Lamotrigine Er Tabs 7)
Lamotrigine Extended Release 100 mg tablets label from Par Health USA, LLC. The label shows 30 tablets in a bottle with the imprint "Par 563". It indicates once-a-day dosing, and includes storage instructions and a caution to dispense the medication guide with each patient. The label also lists the manufacturer and country of origin as China.*
FDA Label Image

Lamotrigine Er Tablets 200 mg Label (Lamotrigine Er Tabs 8)

Lamotrigine Er Tablets 200 mg Label (Lamotrigine Er Tabs 8)
Label for Lamotrigine Extended-Release Tablets 200 mg by Par Health USA, LLC. The label shows this is a 30-tablet package for once-a-day dosing. It includes a caution to dispense the accompanying medication guide, dosage storage instructions, and a barcode. The label also features an image of the round yellow tablets embossed with 'Par' and '564'.*
FDA Label Image

Lamotrigine Er Tablets 250 mg Label (Lamotrigine Er Tabs 9)

Lamotrigine Er Tablets 250 mg Label (Lamotrigine Er Tabs 9)
Label for Lamotrigine Extended Release Tablets 250 mg by Par Health USA, LLC. The label indicates a 30-tablet supply of once-a-day extended-release film-coated tablets. It includes dosage strength, caution to verify product dispensed, storage instructions, and manufacturer information from Zhejiang Huahai Pharmaceutical Co. Ltd. in China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.